排序方式: 共有2条查询结果,搜索用时 31 毫秒
1
1.
Silvia Ramos-Campoy Anna Puiggros Sílvia Be Sandrine Bougeon María Jos Larryoz Dolors Costa Helen Parker Gian Matteo Rigolin Margarita Ortega María Laura Blanco Rosa Collado Rocío Salgado Tycho Baumann Eva Gimeno Carolina Moreno Francesc Bosch Xavier Calvo María Jos Calasanz Antonio Cuneo Jonathan C. Strefford Florence Nguyen-Khac David Oscier Claudia Haferlach Jacqueline Schoumans Blanca Espinet 《Haematologica》2022,107(3):593
Genome complexity has been associated with poor outcome in patients with chronic lymphocytic leukemia (CLL). Previous cooperative studies established five abnormalities as the cut-off that best predicts an adverse evolution by chromosome banding analysis (CBA) and genomic microarrays (GM). However, data comparing risk stratification by both methods are scarce. Herein, we assessed a cohort of 340 untreated CLL patients highly enriched in cases with complex karyotype (CK) (46.5%) with parallel CBA and GM studies. Abnormalities found by both techniques were compared. Prognostic stratification in three risk groups based on genomic complexity (0-2, 3-4 and ≥5 abnormalities) was also analyzed. No significant differences in the percentage of patients in each group were detected, but only a moderate agreement was observed between methods when focusing on individual cases (κ=0.507; P<0.001). Discordant classification was obtained in 100 patients (29.4%), including 3% classified in opposite risk groups. Most discrepancies were technique-dependent and no greater correlation in the number of abnormalities was achieved when different filtering strategies were applied for GM. Nonetheless, both methods showed a similar concordance index for prediction of time to first treatment (TTFT) (CBA: 0.67 vs. GM: 0.65) and overall survival (CBA: 0.55 vs. GM: 0.57). High complexity maintained its significance in the multivariate analysis for TTFT including TP53 and IGHV status when defined by CBA (hazard ratio [HR] 3.23; P<0.001) and GM (HR 2.74; P<0.001). Our findings suggest that both methods are useful but not equivalent for risk stratification of CLL patients. Validation studies are needed to establish the prognostic value of genome complexity based on GM data in future prospective studies. 相似文献
2.
Contador José Pérez-Millan Agnès Guillen Nuria Tort-Merino Adrià Balasa Mircea Falgàs Neus Olives Jaume Castellví Magdalena Borrego-Écija Sergi Bosch Beatriz Fernández-Villullas Guadalupe Ramos-Campoy Oscar Antonell Anna Bargalló Nuria Sanchez-Valle Raquel Sala-Llonch Roser Lladó Albert 《Journal of neurology》2022,269(5):2573-2583
Journal of Neurology - MRI atrophy predicts cognitive status in AD. However, this relationship has not been investigated in early-onset AD (EOAD, < 65 years) patients... 相似文献
1